Intimate Conversations: AI's Impact in Women's Health
Intimate Conversations: AI’s Impact in Women’s Health
Explore how artificial intelligence is reshaping women’s health in this engaging panel discussion. Our expert speakers will dive into the latest trends, challenges, and breakthroughs driven by AI technologies, from personalized care to early diagnosis. Whether you’re a healthcare professional, tech enthusiast, or just interested in the future of women’s wellness, this conversation will offer valuable insights into how innovation is improving outcomes and expanding access in women’s healthcare.
Proud sponsor: Cooley LLP, a leading global law firm specializing in partnering with innovative companies and investors across the life sciences and tech sectors. We're grateful for their support.
Meet Our Panel Speakers:
Svetlana Kazantseva is the CEO of Strawberry Health, dedicated to helping women understand and manage hormonal changes through easy, personalized at-home hormone testing. Her personal passion drives her mission to empower women with the tools and clarity they need to thrive in their bodies and live their healthiest lives.
Dr. Nikole Kimes is the CEO and founder of Siolta Therapeutics, a biotech company pioneering microbiome-based therapies. With over a decade of research in microbial ecology and host-microbe interactions, Dr. Kimes leads a talented team working to develop precision microbial treatments that transform care for inflammatory diseases like asthma.
Event Schedule:
5:30–6:00 PM: Light refreshments + audience arrival
6:00–7:00 PM: 5-minute intro by our sponsor--Cooley LLP, Panel Discussion (Intro, Discussion, Wrap-up)
7:00–7:30 PM: Networking
Meet Our Co-Hosts
Berkeley Pharma Tech Foundation is a nonprofit committed to expanding biotech understanding and improving access to the industry through education, mentorship, and networking. We host roundtables, speaker panels, and community events to connect aspiring scientists and entrepreneurs with industry leaders. Our goals: launch a funded research program within two years and build a state-of-the-art lab in the Bay Area within five. Follow us on LinkedIn or reach out to Vanloan Nguyen to get involved!
Vanloan Nguyen is the founder and president of the Berkeley Pharma Tech Foundation. She is passionate about creating opportunities for others to thrive in the life sciences. Vanloan also serves as founder and CEO of Berkeley Pharma Tech, where she leads the development of innovative healthcare solutions. She is a member of 1891 Angels, a Johns Hopkins alumni investor group, and holds degrees from UC Berkeley and Johns Hopkins University. A first-generation Vietnamese-American, Vanloan brings resilience, curiosity, and a deep sense of purpose to her work—believing strongly in biotechnology’s power to transform lives.